慢性肾脏病中代谢性酸中毒致肾损伤的机制
综述指出慢性代谢性酸中毒是CKD进展的独立可干预危险因素,未治疗者GFR加速下降。其机制涉及代偿性酸排泄增加但伴随肾内旁分泌激素上调及氨诱导补体激活,导致炎症和纤维化;纠正酸中毒可减弱这些反应,可能延缓CKD进展。
要点
- 慢性代谢性酸中毒是CKD进展的可干预危险因素。
- 酸中毒通过上调肾内血管紧张素II、醛固酮和ET-1及氨诱导补体激活促进肾损伤。
- 纠正酸中毒可减轻炎症和纤维化,可能延缓CKD进展。
核心结论
- 慢性代谢性酸中毒通过代偿反应加速CKD进展,纠正酸中毒可减弱这些反应并可能延缓进展。
研究设计与样本
- 综述,基于回顾性分析和单中心前瞻性研究,总结代谢性酸中毒致肾损伤的机制。
主要发现
- 未治疗的慢性代谢性酸中毒常导致CKD患者GFR加速下降。
- 酸中毒上调肾内血管紧张素II、醛固酮和ET-1,慢性升高促进炎症和纤维化。
- 酸中毒刺激氨生成,导致氨诱导的补体激活和C3、C5b-9沉积,引起小管间质损伤。
- 酸中毒治疗可降低血管紧张素II、醛固酮和ET-1水平,减少氨生成,减轻炎症和纤维化。
临床怎么用
- 临床应识别并治疗CKD患者的慢性代谢性酸中毒,以可能延缓肾病进展。
局限性
- 证据主要来自回顾性分析和单中心前瞻性研究,机制总结基于文献综述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retrospective analyses and single-center prospective studies identify chronic metabolic acidosis as an independent and modifiable risk factor for progression of CKD. In patients with CKD, untreated chronic metabolic acidosis often leads to an accelerated reduction in GFR. Mechanisms responsible for this reduction include adaptive responses that increase acid excretion but lead to a decline in kidney function. Metabolic acidosis in CKD stimulates production of intrakidney paracrine hormones including angiotensin II, aldosterone, and endothelin-1 (ET-1) that mediate the immediate benefit of increased kidney acid excretion, but their chronic upregulation promotes inflammation and fibrosis. Chronic metabolic acidosis also stimulates ammoniagenesis that increases acid excretion but also leads to ammonia-induced complement activation and deposition of C3 and C5b-9 that can cause tubule-interstitial damage, further worsening disease progression. These effects, along with acid accumulation in kidney tissue, combine to accelerate progression of kidney disease. Treatment of chronic metabolic acidosis attenuates these adaptive responses; reduces levels of angiotensin II, aldosterone, and ET-1; reduces ammoniagenesis; and diminishes inflammation and fibrosis that may lead to slowing of CKD progression.
引用
- Wesson DE, Buysse JM, Bushinsky DA, et al. Mechanisms of Metabolic Acidosis-Induced Kidney Injury in Chronic Kidney Disease. J Am Soc Nephrol. 2020. PMID: 31988269. doi:10.1681/ASN.2019070677
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。